General Proximity Partners with Daiichi Sankyo for Novel Oncology Solutions Using OmniTAC™ Technology General Proximity announces an innovative collaboration with Daiichi Sankyo, leveraging the OmniTAC™ platform for oncology therapeutics development.

General Proximity Partners with Daiichi Sankyo for Novel Oncology Solutions Using OmniTAC™ Technology #USA #Daiichi_Sankyo #San_Francisco #General_Proximity #OmniTAC

General Proximity Secures $16M to Revolutionize Treatments for 'Undruggable' Diseases With $16 million in new funding, General Proximity aims to advance its innovative medicines targeting undruggable proteins linked to various diseases.

General Proximity Secures $16M to Revolutionize Treatments for 'Undruggable' Diseases #United_States #San_Francisco #Cancer_Treatments #General_Proximity #OmniTAC